Patent details

EP2322233 Title: Nanoparticle formulations for treating vascular disease.

Basic Information

Publication number:
EP2322233
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111545216
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Nanoparticle formulations for treating vascular disease.
French Title of Invention:
Formulations de nanoparticules pour le traitement des maladies vasculaires.
German Title of Invention:
Nanopartikel Formulierungen zur Behandlung von vaskulären Krankheiten.
SPC Number:

Dates

Filing date:
13/06/2008
Grant date:
17/07/2013
EP Publication Date:
17/07/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/05/2011
EP B1 Publication Date:
17/07/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/06/2014
Expiration date:
13/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2008
 
 

Name:
Abbott Cardiovascular Systems Inc.
Address:
3200 Lakeside Drive, Santa Clara, CA 95054, United States (US)

Inventor

1

Name:
Zhao Li
Address:
United States (US)

2

Name:
Astafieva Irina
Address:
United States (US)

3

Name:
Ludwig Florian N.
Address:
Switzerland (CH)

4

Name:
Murase Katsuyuki
Address:
United States (US)

5

Name:
Hossainy Syed F.A.
Address:
United States (US)

Priority

Priority Number:
840119
Priority Date:
16/08/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/51;
Filing date Document type Number of pages